Swiss Advanced Vision

Based in Neuchatel, Switzerland, Swiss Advanced Vision (SAV-IOL) is a medical technology company established in 2009 that develops and manufactures intraocular lenses (IOLs) for patients undergoing cataract surgery. The company's business model centers on the design, production, and worldwide distribution of these advanced ophthalmic implants, which are sold to ophthalmic surgeons and healthcare facilities in over 40 countries. Revenue is generated through the sale of its portfolio of IOLs. The company was founded by Max Boysset, who also serves as CEO and has spearheaded its product development and strategic direction, including fundraising efforts to advance new technologies.

SAV-IOL's core offering revolves around its patented Instant Focus® technology, an Extended Depth of Focus (EDOF) platform designed to provide patients with continuous vision from near to intermediate distances after cataract surgery. This technology utilizes a pseudo-nondiffracting beam (PNDB), which is created by a central aspheric surface on the lens, to elongate the focal point. This approach aims to mimic the natural accommodative function of the eye while minimizing visual disturbances like halos and glare, which can be associated with some multifocal lenses. The IOLs are fabricated from hydrophilic acrylic with a 26% water content and feature a 360° square edge design to help prevent posterior capsular opacification.

The product portfolio includes several lenses built on the Instant Focus® platform. The Lucidis lens is a refractive EDOF IOL that offers an extended range of vision and is positioned as an affordable option. The Eden lens is a premium, hybrid refractive-diffractive model. A significant development was the launch of Harmonis in 2018, the first customizable EDOF IOL. This product allows surgeons to use a web-based configurator to select from over 3,000 optical configurations, tailoring parameters like light distribution and reading distance to individual patient needs and preferences prior to surgery. The company is also developing a next-generation active IOL called R-TASC (Real-Time Autofocus Servo Control), an electronic, app-controlled lens designed for real-time autofocus, for which it has been seeking investment.

Keywords: intraocular lens, EDOF, cataract surgery, Instant Focus technology, pseudo-nondiffracting beam, ophthalmology, medical devices, Lucidis IOL, Harmonis IOL, Eden IOL, presbyopia correction, extended depth of focus, Swiss medtech, ophthalmic implants, Max Boysset, R-TASC, refractive lens, visual accommodation, aspheric optics, custom IOL, toric calculator, vision correction, medical technology, Neuchatel